Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE
KATHERINE 研究显示，对于 HER2 阳性乳腺癌且存在 HER2 阴性残留浸润性疾病的患者，辅助曲妥珠单抗-美坦新治疗效果良好。
期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-022-00477-z
Loibl, Sibylle; Huang, Chiun-Sheng; Mano, Max S; Mamounas, Eleftherios P; Geyer, Charles E Jr; Untch, Michael; Thery, Jean-Christophe; Schwaner, Ingo; Limentani, Steven; Loman, Niklas; Lübbe, Kristina; Chang, Jenny C; Hatschek, Thomas; Tesarowski, David; Song, Chunyan; Lysbet de Haas, Sanne; Boulet, Thomas; Lambertini, Chiara; Wolmark, Norman
